HIF2α, A Key Player in Kras-Mediated Pancreatic Neoplasia

被引：0
作者：
Criscimanna, A. [1 ]
Speicher, J. [1 ]
Esni, F. [1 ]
机构：
[1] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA
来源：
PANCREAS | 2011年 / 40卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1318 / 1318
页数：1
相关论文
共 50 条
  • [31] Deficiency in PHD2-mediated hydroxylation of HIF2α underlies Pacak-Zhuang syndrome
    Ferens, Fraser G.
    Taber, Cassandra C.
    Stuart, Sarah
    Hubert, Mia
    Tarade, Daniel
    Lee, Jeffrey E.
    Ohh, Michael
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [32] Deficiency in PHD2-mediated hydroxylation of HIF2α underlies Pacak-Zhuang syndrome
    Fraser G. Ferens
    Cassandra C. Taber
    Sarah Stuart
    Mia Hubert
    Daniel Tarade
    Jeffrey E. Lee
    Michael Ohh
    Communications Biology, 7
  • [33] KRAS-mediated epigenetic reprogramming upregulates RELB-dependent CXCR2 expression to promote transformation
    Durand, Joel
    Baldwin, Albert
    CANCER RESEARCH, 2015, 75
  • [34] KRAS G12C mutation: from black sheep to key player in pancreatic cancer treatment
    Ibrahim, Rebecca
    Khoury, Rita
    Ibrahim, Tony
    Assi, Tarek
    Cesne, Axel Le
    FUTURE ONCOLOGY, 2023, 19 (07) : 485 - 488
  • [35] Jorunnamycin A induces apoptosis in pancreatic ductal adenocarcinoma cells, spheroids, and patient-derived organoids by modulating KRAS-mediated survival pathways
    Khine, Hnin Ei Ei
    Suriya, Utid
    Rungrotmongkol, Thanyada
    Chamni, Supakarn
    Lu, Yanxi
    Benard, Alan
    Lan, Bin
    Mukhopadhyay, Debabrata
    Chang, David
    Biankin, Andrew
    Schneider-Stock, Regine
    Gruetzmann, Robert
    Sungthong, Rungroch
    Pilarsky, Christian
    Chaotham, Chatchai
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [36] KRAS-mediated Up-regulation of RRM2 Expression Is Essential for the Proliferation of Colorectal Cancer Cell Lines
    Yoshida, Yasuhiro
    Tsunoda, Toshiyuki
    Doi, Keiko
    Tanaka, Yoko
    Fujimoto, Takahiro
    Machida, Takashi
    Ota, Takeharu
    Koyanagi, Midori
    Takashima, Yasuo
    Sasazuki, Takehiko
    Kuroki, Masahide
    Iwasaki, Akinori
    Shirasawa, Senji
    ANTICANCER RESEARCH, 2011, 31 (07) : 2535 - 2539
  • [37] KRAS2 gene mutations in acinar-ductal metaplasia in the pancreas:: Pancreatic neoplasia may start prior to pancreatic intraepithelial neoplasia lesions
    Shi, C.
    Hong, S-M
    Lim, P.
    Kamiyama, H.
    Goggins, M.
    Hruban, R. H.
    Eshleman, J. R.
    LABORATORY INVESTIGATION, 2008, 88 : 316A - 316A
  • [38] KRAS2 gene mutations in acinar-ductal metaplasia in the pancreas:: Pancreatic neoplasia may start prior to pancreatic Intraepithelial neoplasia lesions
    Shi, C.
    Hong, S-M
    Lim, P.
    Kamiyama, H.
    Goggins, A.
    Hruban, R. H.
    Eshleman, J. R.
    MODERN PATHOLOGY, 2008, 21 : 316A - 316A
  • [39] TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal Transition
    Morin, Aurelie
    Goncalves, Judith
    Moog, Sophie
    Castro-Vega, Luis-Jaime
    Job, Sylvie
    Buffet, Alexandre
    Fontenille, Marie-Josephine
    Woszczyk, Justine
    Gimenez-Roqueplo, Anne-Paule
    Letouze, Eric
    Favier, Judith
    CELL REPORTS, 2020, 30 (13): : 4551 - +
  • [40] Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer
    Cronin, Shane J. F.
    Rao, Shuan
    Tejada, Miguel A.
    Turnes, Bruna Lenfers
    Licht-Mayer, Simon
    Omura, Takao
    Brenneis, Christian
    Jacobs, Emily
    Barrett, Lee
    Latremoliere, Alban
    Andrews, Nick
    Channon, Keith M.
    Latini, Alexandra
    Arvanites, Anthony C.
    Davidow, Lance S.
    Costigan, Michael
    Rubin, Lee L.
    Penninger, Josef M.
    Woolf, Clifford J.
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (660)
12345